Sunscreen and lip manufacturing: two categories, two regulators
Sunscreen is the clearest example in cosmetics of the same jar being a drug in one market and a cosmetic in another. Lip products carry a smaller version of the same problem, plus a swallow-risk question.
Sunscreen manufacturing: what a sunscreen manufacturer must prove
In the United States, sunscreen is regulated as an over-the-counter drug, not as a cosmetic. That changes what you must be able to show — including whether the product meets the applicable monograph. In the European Union the same product is treated as a cosmetic, which moves the emphasis to the safety assessment and labelling regime. Read EU cosmetic regulation for the EU side.
Lip balm manufacturing: what a lip balm manufacturer must handle
- Colour is regulated as a colour additive when pigment is used, exactly as in other colour cosmetics — see the vetting guide for how that fits into supplier documents.
- Ingestion risk is designed for, not ignored. A lip product is partly swallowed, so the safety assessment has to account for that exposure path. This is a formulation and assessment question, not a labelling one.
- The pack is the applicator. A stick, a squeeze tube and a pot present the product very differently and interact with the formula differently.
What to settle before you brief a factory
- Which markets are you selling into first? That single answer decides the regime.
- For sunscreen, does the intended formula fit an existing monograph, or does it need another route?
- For lip products, does the formula include colour, and if so is it a certified colour?
- Which pack, and has the formula been tested in it?
The categories around this one differ in specific ways: hair care is a viscosity and surfactant problem — see hair care manufacturing — and perfume is driven by a separate fragrance supply chain — see perfume manufacturing.
Related reading
- Perfume Manufacturing — Alcohol, Transport and the Fragrance BriefA perfume manufacturer is a different supplier from a skincare one: the alcohol base changes transport classification, and the fragrance house controls the formula. What to sort out first.
- Hair Care Manufacturing — Viscosity, Surfactants and Big PacksHair care manufacturing is a viscosity and surfactant problem with large-pack economics. What a hair care manufacturer must control, and the questions that separate a real one from a filler.
- Skincare Manufacturing — What Actually Decides QualityThe real variables in skincare manufacturing are the emulsion system and its stability, not the ingredient list on the marketing page. What to ask a skincare factory before you commit.
Frequently asked questions
Is sunscreen a cosmetic or a drug?
It depends on the market. In the United States sunscreen is regulated as an over-the-counter drug; in the European Union it is treated as a cosmetic. The destination market decides which regime applies, and the two ask for different evidence.
What does sunscreen's US drug status change for me?
It changes what you must be able to demonstrate, including whether the product meets the applicable over-the-counter monograph. Treat the evidence requirements as stricter than for a plain cosmetic.
Do lip products need colour additive approval?
If the formula contains pigment, yes — the colour additive rules apply just as they do for other colour cosmetics, including batch certification for colours that require it.
Why do lip products need special safety consideration?
Because a lip product is partly ingested, the safety assessment has to account for oral exposure. That is a formulation and assessment question rather than something a label can resolve.
Can one formula be sold as cosmetics in the EU and a drug in the US?
The classification is market-specific, so the same product may fall under different regimes. Plan your evidence and labelling per market rather than assuming a single category worldwide.
What is the biggest mistake brands make with suncare?
Assuming a single regulatory category applies everywhere. Because the US and the EU treat sunscreen differently, a plan built on one market's rules often fails the other's.